Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
CPRX - Catalyst Pharmaceuticals, Inc.
Market Cap 1.45B P/E 15.31 EPS this Y 74.60% Ern Qtrly Grth 8.00%
Income 68.15M Forward P/E 6.54 EPS next Y 26.40% 50D Avg Chg 6.00%
Sales 434.48M PEG - EPS past 5Y 32.93% 200D Avg Chg -12.00%
Dividend N/A Price/Book 4.28 EPS next 5Y - 52W High Chg -39.00%
Recommedations 1.60 Quick Ratio 4.69 Shares Outstanding 118.69M 52W Low Chg 29.00%
Insider Own 6.01% ROA 9.33% Shares Float 102.43M Beta 0.76
Inst Own 83.49% ROE 13.85% Shares Shorted/Prior 5.92M/5.05M Price 13.47
Gross Margin 65.18% Profit Margin 15.69% Avg. Volume 1,882,258 Target Price 30.14
Oper. Margin 44.21% Earnings Date Nov 6 Volume 1,029,018 Change -2.04%
Healthcare | Biotechnology | United States
About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Catalyst Pharmaceuticals, Inc. News
12/24/24 Neurocrine Biosciences Stock Sees RS Rating Upgrade
12/24/24 Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
12/18/24 Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
12/16/24 Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/11/24 NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
12/06/24 Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?
12/03/24 Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
12/02/24 Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
09:50 AM Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
11/25/24 Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List
11/19/24 Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
11/15/24 Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
11/13/24 Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
11/13/24 Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point
11/11/24 Vericel Stock Sees RS Rating Shoot Higher
11/10/24 Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
11/08/24 With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case
11/07/24 Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
11/06/24 Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say
11/06/24 Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DENKHAUS DONALD A Director Director Feb 05 Option 4.01 40,000 160,400 434,333 02/06/24
MCENANY PATRICK J - - Jan 02 Option 1.13 250,000 282,500 4,385,256 01/03/24
Tierney David S Director Director Jan 02 Option 1.13 10,000 11,300 344,874 01/03/24
O'Keeffe Charles B Director Director Jan 02 Option 1.13 60,000 67,800 681,724 01/03/24
Miller Steve Chief Op. & Scientif.. Chief Op. & Scientific Officer Dec 11 Option 1.13 150,000 169,500 797,457 12/13/23
Daly Richard J Director Director Dec 07 Option 1.13 60,000 67,800 208,000 12/11/23
INGENITO GARY Chief Med. & Reg. Of.. Chief Med. & Reg. Officer Dec 06 Sell 14.02 50,000 701,000 38,367 12/08/23
INGENITO GARY Chief Med. & Reg. Of.. Chief Med. & Reg. Officer Dec 06 Option 1.13 50,000 56,500 88,367 12/08/23
Tierney David S Director Director May 11 Option 0.79 20,000 15,800 333,541 05/12/23
Miller Steve Chief Operating Offi.. Chief Operating Officer May 11 Option 0.79 100,000 79,000 687,457 05/12/23
Tierney David S Director Director Apr 05 Sell 16.83 30,000 504,900 313,541 04/07/23
Tierney David S Director Director Apr 05 Option 0.79 30,000 23,700 343,541 04/07/23
Del Carmen Jeffrey Chief Commercial Off.. Chief Commercial Officer Mar 29 Sell 16.7 40,000 668,000 7,541 03/30/23
Del Carmen Jeffrey Chief Commercial Off.. Chief Commercial Officer Mar 29 Option 3.23 40,000 129,200 26,558 03/30/23
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Mar 28 Sell 16.59 108,216 1,795,303 50,557 03/30/23
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Mar 28 Option 0.96 108,216 103,887 100,557 03/30/23
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Mar 22 Sell 16.46 41,784 687,765 50,557 03/24/23
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Mar 22 Option 0.79 41,784 33,009 89,081 03/24/23
INGENITO GARY Chief Medical Office.. Chief Medical Officer Dec 06 Sell 16.85 5,918 99,718 30,802 12/08/22
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Nov 22 Sell 16.527 120,000 1,983,240 27,442 11/23/22
Miller Steve Chief Operating Offi.. Chief Operating Officer Nov 21 Sell 16.31 100,000 1,631,000 553,791 11/23/22
COELHO PHILIP H Director Director Nov 21 Sell 16.66 100,000 1,666,000 149,553 11/23/22
MCENANY PATRICK J President and CEO President and CEO Nov 18 Option 2.24 500,000 1,120,000 4,052,606 11/22/22
MCENANY PATRICK J President and CEO President and CEO Nov 18 Sell 15.48 500,000 7,740,000 3,902,606 11/22/22
O'Keeffe Charles B Director Director Nov 15 Sell 16.037 87,985 1,411,015 565,057 11/17/22
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Nov 15 Sell 15.768 60,000 946,080 147,442 11/17/22
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Sep 16 Sell 13.496 90,000 1,214,640 267,442 09/20/22
DENKHAUS DONALD A Director Director Sep 14 Sell 15.34 20,000 306,800 297,666 09/15/22
MCENANY PATRICK J President and CEO President and CEO Sep 13 Sell 15.37 1,027,611 15,794,381 3,902,606 09/15/22
Miller Steve Chief Operating Offi.. Chief Operating Officer Sep 13 Sell 16.99 107,933 1,833,782 653,791 09/15/22
COELHO PHILIP H Director Director Sep 13 Sell 15.73 30,000 471,900 249,553 09/15/22
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Aug 26 Sell 14.26 68,095 971,035 407,442 08/30/22
Daly Richard J Director Director Aug 24 Option 2.53 40,000 101,200 92,666 08/26/22
Tierney David S Director Director Aug 22 Option 2.53 20,000 50,600 328,207 08/23/22
Tierney David S Director Director Aug 22 Sell 14.16 20,000 283,200 308,207 08/23/22
Del Carmen Jeffrey Chief Commercial Off.. Chief Commercial Officer Aug 19 Sell 14.05 14,140 198,667 08/22/22
O'Keeffe Charles B Director Director Aug 18 Option 2.53 40,000 101,200 653,042 08/19/22
Miller Steve Chief Operating Offi.. Chief Operating Officer Aug 18 Sell 13.5 150,000 2,025,000 761,724 08/19/22
Miller Steve Chief Operating Offi.. Chief Operating Officer Aug 18 Option 2.53 150,000 379,500 793,149 08/19/22
MCENANY PATRICK J President and CEO President and CEO Aug 18 Option 2.53 300,000 759,000 5,055,217 08/19/22
MCENANY PATRICK J President and CEO President and CEO Aug 18 Sell 13.97 300,000 4,191,000 4,930,217 08/19/22
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Aug 17 Option 2.53 150,000 379,500 494,796 08/19/22
GRANDE ALICIA VP, Treasurer and CF.. VP, Treasurer and CFO Aug 17 Sell 13.81 150,000 2,071,500 475,537 08/19/22
COELHO PHILIP H Director Director Aug 17 Option 2.53 40,000 101,200 279,553 08/19/22
INGENITO GARY Chief Medical & Reg... Chief Medical & Reg. Officer Jun 21 Option 4.13 150,000 619,500 28,205 06/23/22
INGENITO GARY Chief Medical & Reg... Chief Medical & Reg. Officer Jun 21 Sell 6.6 150,000 990,000 22,053 06/23/22
Tierney David S Director Director May 20 Option 2.53 20,000 50,600 328,207 05/24/22
Daly Richard J Director Director Jan 25 Option 3.35 50,000 167,500 52,666 01/26/22
DENKHAUS DONALD A Director Director Jan 10 Option 2.53 40,000 101,200 317,666 01/11/22
Miller Steve Chief Operating Offi.. Chief Operating Officer Aug 26 Sell 5.56 80,000 444,800 741,724 08/26/21